Stay updated on Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial
Sign up to get notified when there's something new on the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page.

Latest updates to the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedThe page’s displayed site revision version was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check23 days agoChange DetectedRevision v3.5.2 was added and revision v3.5.0 was removed from the study record history.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision 3.5.0 was added to the history. Revision 3.4.3 was removed from the history.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision v3.4.3 was added and revision v3.4.2 was removed from the record history.SummaryDifference0.1%

- Check87 days agoChange DetectedThe history shows a new revision entry (v3.4.2) indicating an update to the study record; a government funding notice and the prior revision note (v3.4.1) were removed.SummaryDifference0.9%

- Check95 days agoChange DetectedA government funding notice banner was added and the page revision updated to v3.4.1, replacing the previous v3.4.0 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

Stay in the know with updates to Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page.